Clinical application of heparin-coated cardiopulmonary bypass equipment during perfusion with low systemic heparinization is reported with special emphasis on patients refusing any transfusion of homologous blood or blood products. Using the described technique, coronary artery revascularization was successfully performed in three Jehovah's witnesses. During perfusion, the activated clotting time (ACT) was maintained above 180 seconds. Prebypass haematocrit was 38±3% and dropped to 22±2% during cardiopulmonary bypass in complete haemodilution. However, the haematocrit was 28±1 % at 24 hours after cardiopulmonary bypass and 32±1 % after seven days. Hence, cardiopulmonary bypass with low systemic heparinization may further reduce bypass induced morbidity and improve the final outcome in selected patients.
Krause AH, Ferguson TB, Roper CL, Weldon CSThoracic aneurysmectomy utilizing the TDMAC-Heparin. Ann Surg1972; 14: 123-32.
4.
Ishihara K., Nakae S., Tsuchida H. et al. Clinical experiences with the anthron bypass tube for aortic surgeries. Jpn J Artif Organs1985; 14: 985-88.
5.
Larm O., Larsson R., Olsson P.A new nonthrombogenic surface prepared by selective covalent binding of heparin via a modified reducing terminal residue. Biomater Med DevicesArtif Organs1983; 11: 161-73.
6.
von Segesser LK, Weiss BM, Gallino A., Redha F., von Felten A., Turina M.Superior hemodynamics in left heart bypass without systemic heparinization. European J Cardiothorac Surg1989; 4: 384-89.
7.
von Segesser LK, Weiss BM, Turina M.Perfusion with heparin coated equipment: potential for clinical use. Seminars in Thoracic and Cardiovascular Surgery1990; 2: 373-80.
8.
von Segesser LK, Turina M.Heparin coated hollow fiber oxygenator without systemic heparinization in comparison to classic bubble and membrane oxygenators . Proceedings of the 26th International Conference of the American Society of Extracorporeal Technology, Anaheim, March 11-14, 1988: 76-80.
9.
von Segesser LK, Turina M.Cardiopulmonary bypass without systemic heparinization: performance of heparin coated oxygenators in comparison to classic membrane and bubble oxygenators. J Thorac Cardiovasc Surg1989; 98: 386-96.
10.
von Segesser LK, Turina M.Long term cardiopulmonary bypass without systemic heparinization. Int J Artif Organs1990; 13: 687-91.
11.
Toomasian JM , Hsu LC, Hirschl RB, Heiss KF, Hultquist KA, Bartlett RHEvaluation of Duraflo II heparin coating in prolonged extracorporeal membrane oxygenation. ASAIO Trans1988; 34: 410-14.
12.
Mottaghy K. , Oedekoven B., Schaich-Lester D., Pöppel K., Küpper W.Application of surfaces with end-point attached heparin to extracorporeal circulation with membrane lungs. Trans Am Soc Artif Intern Organs1989; 35: 146-52.
13.
von Segesser LK, Lachat M., Leskosek B. et al. Cardiopulmonary bypass with low systemic heparinization: an experimental study. Perfusion1990; 5: 267-76.
14.
von Segesser LK, Weiss BM, Carrel T et al. Experimental evaluation of heparin coated cardiopulmonary bypass equipment with low systemic heparinization and high dose aprotinin (unpublished observations).
15.
von Segesser LK, Lachat M., Gallino A. et al. Performance characteristics of centrifugal pumps with attached heparin surface coating. Thorac Cardiovasc Surg1990; 38: 224-28.
16.
Bindslev L. , Eklund J., Norlander O. et al. Treatment of acute respiratory failure by extracorporeal carbon dioxide elimination performed with a surface heparinized artificial lung. Anesthesiology1987; 67: 117-20.
17.
von Segesser LK , Weiss BM, Garcia E., Gallino A., Turina M.Reduced blood loss and transfusion requirements with low systemic heparinization: preliminary clinical results in coronary artery revascularization. Eur J Cardiothorac Surg1990; 4: 639-43.
18.
von Segesser LK.Arterial grafting for myocardial revascularization. Berlin : Springer Verlag, 1990: 49-80.
19.
Ott DA, Cooley DACardiovascular surgery in Jehovah's witnesses. Report on 542 operations without blood transfusions. JAMA1977; 238: 1256-58.
20.
Wong Dhw, Jenkins LCSurgery in Jehovah's witnesses. Can J Anaesth1989; 36: 578-85.
